| Olivia F Mittel, MD | |
|
231 E Chestnut St, Louisville, KY 40202-1821 | |
| (502) 629-6000 | |
| (502) 852-4989 |
| Full Name | Olivia F Mittel |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 231 E Chestnut St, Louisville, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013170901 | NPI | - | NPPES |
| 201029060 | Medicaid | IN | |
| 7100167950 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 44682 (Kentucky) | Primary |
| Entity Name | Community Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588614994 PECOS PAC ID: 7012811284 Enrollment ID: O20031120000656 |
News Archive
Samuel K. Sia, assistant professor of biomedical engineering at Columbia Engineering, has developed an innovative strategy for an integrated microfluidic-based diagnostic device-in effect, a lab-on-a-chip-that can perform complex laboratory assays, and do so with such simplicity that these tests can be carried out in the most remote regions of the world.
GW Pharmaceuticals plc announced today it has commenced a Phase 1 clinical trial of product candidate GWP42006 for the treatment of epilepsy.
Dr Rachel Colls says size and colour of shop changing rooms, as well as the position and size of shop mirrors, influence women's perception of their bodies.
TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T cells to treat severe chronic inflammatory and autoimmune diseases, today announces the signature of a strategic R&D collaboration agreement with the Lübeck Institute of Experimental Dermatology, a leading institution in the field of translational research on skin blistering diseases, part of the University of Lübeck in Germany.
Scientists at the European Molecular Biology Laboratory and the German Cancer Research Centre, both in Heidelberg, Germany, have developed a new method that uncovers the combined effects of genes.
› Verified 1 days ago
| Entity Name | University Of Louisville Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366722316 PECOS PAC ID: 3476725599 Enrollment ID: O20111017000036 |
News Archive
Samuel K. Sia, assistant professor of biomedical engineering at Columbia Engineering, has developed an innovative strategy for an integrated microfluidic-based diagnostic device-in effect, a lab-on-a-chip-that can perform complex laboratory assays, and do so with such simplicity that these tests can be carried out in the most remote regions of the world.
GW Pharmaceuticals plc announced today it has commenced a Phase 1 clinical trial of product candidate GWP42006 for the treatment of epilepsy.
Dr Rachel Colls says size and colour of shop changing rooms, as well as the position and size of shop mirrors, influence women's perception of their bodies.
TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T cells to treat severe chronic inflammatory and autoimmune diseases, today announces the signature of a strategic R&D collaboration agreement with the Lübeck Institute of Experimental Dermatology, a leading institution in the field of translational research on skin blistering diseases, part of the University of Lübeck in Germany.
Scientists at the European Molecular Biology Laboratory and the German Cancer Research Centre, both in Heidelberg, Germany, have developed a new method that uncovers the combined effects of genes.
› Verified 1 days ago
| Entity Name | Norton Childrens Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326695255 PECOS PAC ID: 3779917596 Enrollment ID: O20200102000758 |
News Archive
Samuel K. Sia, assistant professor of biomedical engineering at Columbia Engineering, has developed an innovative strategy for an integrated microfluidic-based diagnostic device-in effect, a lab-on-a-chip-that can perform complex laboratory assays, and do so with such simplicity that these tests can be carried out in the most remote regions of the world.
GW Pharmaceuticals plc announced today it has commenced a Phase 1 clinical trial of product candidate GWP42006 for the treatment of epilepsy.
Dr Rachel Colls says size and colour of shop changing rooms, as well as the position and size of shop mirrors, influence women's perception of their bodies.
TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T cells to treat severe chronic inflammatory and autoimmune diseases, today announces the signature of a strategic R&D collaboration agreement with the Lübeck Institute of Experimental Dermatology, a leading institution in the field of translational research on skin blistering diseases, part of the University of Lübeck in Germany.
Scientists at the European Molecular Biology Laboratory and the German Cancer Research Centre, both in Heidelberg, Germany, have developed a new method that uncovers the combined effects of genes.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Olivia F Mittel, MD Po Box 909, Louisville, KY 40201-0909 Ph: (502) 629-6000 | Olivia F Mittel, MD 231 E Chestnut St, Louisville, KY 40202-1821 Ph: (502) 629-6000 |
News Archive
Samuel K. Sia, assistant professor of biomedical engineering at Columbia Engineering, has developed an innovative strategy for an integrated microfluidic-based diagnostic device-in effect, a lab-on-a-chip-that can perform complex laboratory assays, and do so with such simplicity that these tests can be carried out in the most remote regions of the world.
GW Pharmaceuticals plc announced today it has commenced a Phase 1 clinical trial of product candidate GWP42006 for the treatment of epilepsy.
Dr Rachel Colls says size and colour of shop changing rooms, as well as the position and size of shop mirrors, influence women's perception of their bodies.
TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T cells to treat severe chronic inflammatory and autoimmune diseases, today announces the signature of a strategic R&D collaboration agreement with the Lübeck Institute of Experimental Dermatology, a leading institution in the field of translational research on skin blistering diseases, part of the University of Lübeck in Germany.
Scientists at the European Molecular Biology Laboratory and the German Cancer Research Centre, both in Heidelberg, Germany, have developed a new method that uncovers the combined effects of genes.
› Verified 1 days ago
Dr. Kendra Stratton Cloyd, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3026 Poplar Level Rd, Louisville, KY 40217 Phone: 502-636-4929 | |
Meredith Kay Irwin, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 100 Mallard Creek Rd Ste 395, Louisville, KY 40207 Phone: 502-895-9421 Fax: 502-899-5762 | |
Julia E Richerson, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2215 Portland Ave, Louisville, KY 40212 Phone: 502-774-8631 Fax: 502-776-8912 | |
Pradip D Patel, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 9702 Stonestreet Rd, Ste 100, Louisville, KY 40272 Phone: 502-588-0610 Fax: 502-588-0611 | |
Patricia Gail Williams, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 411 E Chestnut St, Louisville, KY 40202 Phone: 502-588-0850 Fax: 502-588-0861 | |
Teresa Crase, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 9880 Angies Way, Ste. 400, Louisville, KY 40241 Phone: 502-394-6500 | |
Dr. Kenneth N Schikler, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 210 E Gray St, Ste 1000, Louisville, KY 40202 Phone: 502-629-7702 Fax: 502-629-3975 |